The Penrose leadership team is responsible for bringing our mission to life.

David Sherris, Ph.D.

President and Chief Executive Officer

Dr. David Sherris brings over three decades of experience to the Penrose table in translational medicine involving basic research, pharmaceutics and diagnostics.

Jasrai S. Gill, M.D., M.B.A.

Chief Medical Officer

Dr. Gill is a practicing cardio-oncologist with extensive experience in healthcare management and is a founding member of Penrose TherapeuTx.

Bhardwaj Desai, M.D.

Chief Development Officer

Dr. Desai is a trained medical oncologist and hematologist with more than two decades of oncology clinical research expertise across all phases of drug development.

Bennett C. Borer, Ph.D.

Director of Chemistry, Manufacturing, and Controls

Dr. Borer has extensive pharmaceutical and biotechnology experience, having worked with some of the world’s most innovative biopharmaceutical companies leading drug discovery through to new drug approval (NDA) filings.

Christopher W. Schutt

Chief Financial Officer & Chief Operating Officer

Mr. Schutt has over a decade of experience in balance sheet optimization, corporate finance, investment banking, and business development with publicly traded and privately held financial institutions ranging from $250 million to $25 billion in assets. He is also a founding member of Penrose TherapeuTx.